Lexeo Therapeutics, Inc. (LXEO)
4.07
-0.13
(-3.10%)
USD |
NASDAQ |
Sep 21, 16:00
4.07
0.00 (0.00%)
After-Hours: 20:00
Lexeo Therapeutics Total Assets (Quarterly) : 254.90M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 254.90M |
| March 31, 2026 | 250.36M |
| December 31, 2025 | 271.13M |
| September 30, 2025 | 143.84M |
| June 30, 2025 | 176.07M |
| March 31, 2025 | 125.69M |
| December 31, 2024 | 149.92M |
| September 30, 2024 | 173.86M |
| Date | Value |
|---|---|
| June 30, 2024 | 192.01M |
| March 31, 2024 | 213.20M |
| December 31, 2023 | 143.17M |
| September 30, 2023 | 54.72M |
| June 30, 2023 | 64.94M |
| March 31, 2023 | 77.82M |
| December 31, 2022 | 101.31M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 2.112B |
| Oncolytics Biotech, Inc. | 7.671M |
| Sangamo Therapeutics, Inc. | 59.96M |
| Sarepta Therapeutics, Inc. | 3.189B |
| Anixa Biosciences, Inc. | 15.07M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 19.84M |
| Shareholders Equity (Quarterly) | 235.06M |
| Debt to Equity Ratio | 0.029 |
| Current Ratio | 13.89 |
| Net Debt Paydown Yield | 0.14% |